SYROS PHARMACEUTICALS, INC. Shareholders' Equity
SYROS PHARMACEUTICALS, INC. had Shareholders' Equity of -$11.12 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-10-31
- 2024-09-30: Stockholders' Equity Attributable to Parent -$11.12M.
- 2024-06-30: Stockholders' Equity Attributable to Parent -$6.35M.
- 2024-03-31: Stockholders' Equity Attributable to Parent $15.06M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $16.66M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2024-09-30 | -$11.12M 10-Q · filed 2024-10-31 |
| 2024-06-30 | -$6.35M 10-Q · filed 2024-10-31 |
| 2024-03-31 | $15.06M 10-Q · filed 2024-07-31 |
| 2023-12-31 | $16.66M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $36.30M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $73.24M 10-Q · filed 2024-10-31 |
| 2023-03-31 | $106.75M 10-Q · filed 2024-07-31 |
| 2022-12-31 | $127.74M 10-Q · filed 2024-10-31 |
| 2022-09-30 | $129.17M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $31.02M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $62.74M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $85.22M 10-K · filed 2024-03-27 |
| 2021-09-30 | $106.06M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $129.98M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $149.88M 10-Q · filed 2022-08-09 |
| 2020-12-31 | $90.55M 10-K · filed 2023-03-02 |
| 2020-09-30 | $45.94M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $62.41M 10-Q · filed 2021-11-05 |
| 2020-03-31 | $76.54M 10-Q · filed 2021-08-05 |
| 2019-12-31 | $79.18M 10-K · filed 2023-03-02 |
| 2019-09-30 | $94.57M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $111.92M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $64.02M 10-Q · filed 2020-08-06 |
| 2018-12-31 | $78.59M 10-K · filed 2022-03-15 |
| 2018-09-30 | $94.84M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $108.71M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $104.50M 10-Q · filed 2019-08-01 |
| 2017-12-31 | $65.32M 10-K · filed 2021-03-04 |
| 2017-09-30 | $78.59M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $91.08M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $70.14M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $80.60M 10-K · filed 2020-03-05 |
| 2016-09-30 | $90.78M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$68.41M 10-Q · filed 2016-08-15 |
| 2015-12-31 | -$47.96M 10-K · filed 2019-03-07 |
| 2014-12-31 | -$21.77M 10-K · filed 2018-03-12 |
| 2013-12-31 | -$9.29M 10-K · filed 2017-03-20 |